Company profile
Terns Pharmaceuticals, Inc. Insider Trading
TERNEvery SEC Form 4 insider trading filing for Terns Pharmaceuticals, Inc. (TERN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001831363
- Filings
- 94
- Insiders
- 27
- Last filing
- 2026-05-05
Activity summary
No insider transactions in the last 30 days. The most recent was on May 5, 2026, when Andrew Gengos sold 40,503 shares. 94 filings from 27 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Terns Pharmaceuticals, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $16.0M.
No insider activity recorded for TERN in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 5, 2026 | Andrew Gengos | TERN | U | 40,503 | $53.00 | $2.15M |
| May 5, 2026 | Andrew Gengos | TERN | Disposition | 68,750 | $53.00 | $3.64M |
| May 5, 2026 | Andrew Gengos | TERN | Disposition | 750,000 | — | — |
| May 5, 2026 | Andrew Gengos | TERN | Disposition | 137,500 | — | — |
| May 5, 2026 | Emil Kuriakose | TERN | U | 24,562 | $53.00 | $1.30M |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TERN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.